Skip to main content
OpenTrials
Completed

NCT Number: NCT02781987

Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic Pancreatitis

The purpose of this study is to compare the incidence of post-ERCP pancreatitis (PEP) in chronic pancreatitis (CP) patients to that in biliary disease patients, to determine whether CP patients in early clinical stage have a higher PEP incidence, and to identify the predictive and protective factors for PEP in chronic pancreatitis patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post-ERCP Acute Pancreatitis

Age range

5 year–85 year

Sex eligibility

All sexes

Study type

Observational

About this study

Analysis of patients with chronic pancreatitis (CP group) and biliary disease (BD group) in Changhai Hospital from January 2011 to May 2015 were conducted. Difference of PEP incidences between BD group and CP group, as well as between M-ANNHEIM subcategories were calculated by chi-square test or Fisher's exact test. The predictive and protective factors for PEP were investigated by univariate and multivariate analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with an endoscope inserted to cannulate the pancreatic/biliary duct were included.

Exclusion criteria

  • patients in whom the papilla of Vater was not reached;
  • patients who underwent stent removal procedures without ductal cannulation;
  • patients in whom the intubation was failed.

Treatment and study plan

chronic pancreatitis

Other

patients with chronic pancreatitis

Primary outcomes

  1. Numbers of chronic pancreatitis patients with post-ERCP pancreatitis, diabetes mellitus, steatorrhea, previous pancreatitis, previous PEP, pancreatic divisum, jaundice, ESWL, pancreatic duct stone, drainage and minor papilla pancreatogram.

    Time frame: 8 months

Secondary outcomes

  1. Numbers of biliary disease patients with post-ERCP pancreatitis, previous pancreatitis and previous PEP.

    Time frame: 2 months

Sponsors and collaborators

Lead sponsor

Changhai Hospital

Other

Registry information

Official study title

Changhai Hospital, the Second Military Medical University

Important dates

Study start
2011
Primary completion
2015
Study completion
2015
First posted
May 25, 2016
Registry last updated
Jan 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.